key: cord-0989051-xl9rwld2 authors: Anderson, George; Reiter, Russel J. title: Melatonin: Roles in influenza, Covid‐19, and other viral infections date: 2020-04-21 journal: Rev Med Virol DOI: 10.1002/rmv.2109 sha: d9d5487137cc79931387a5c58d36e99f7f5a1654 doc_id: 989051 cord_uid: xl9rwld2 There is a growing appreciation that the regulation of the melatonergic pathways, both pineal and systemic, may be an important aspect in how viruses drive the cellular changes that underpin their control of cellular function. We review the melatonergic pathway role in viral infections, emphasizing influenza and covid‐19 infections. Viral, or preexistent, suppression of pineal melatonin disinhibits neutrophil attraction, thereby contributing to an initial “cytokine storm”, as well as the regulation of other immune cells. Melatonin induces the circadian gene, Bmal1, which disinhibits the pyruvate dehydrogenase complex (PDC), countering viral inhibition of Bmal1/PDC. PDC drives mitochondrial conversion of pyruvate to acetyl‐coenzyme A (acetyl‐CoA), thereby increasing the tricarboxylic acid cycle, oxidative phosphorylation, and ATP production. Pineal melatonin suppression attenuates this, preventing the circadian “resetting” of mitochondrial metabolism. This is especially relevant in immune cells, where shifting metabolism from glycolytic to oxidative phosphorylation, switches cells from reactive to quiescent phenotypes. Acetyl‐CoA is a necessary cosubstrate for arylalkylamine N‐acetyltransferase, providing an acetyl group to serotonin, and thereby initiating the melatonergic pathway. Consequently, pineal melatonin regulates mitochondrial melatonin and immune cell phenotype. Virus‐ and cytokine‐storm‐driven control of the pineal and mitochondrial melatonergic pathway therefore regulates immune responses. Virus‐and cytokine storm‐driven changes also increase gut permeability and dysbiosis, thereby suppressing levels of the short‐chain fatty acid, butyrate, and increasing circulating lipopolysaccharide (LPS). The alterations in butyrate and LPS can promote viral replication and host symptom severity via impacts on the melatonergic pathway. Focussing on immune regulators has treatment implications for covid‐19 and other viral infections. Viruses, including SARS, and influenza, can change quickly, thereby negating the efficacy of developed vaccines and targetted antiviral drugs. 1 Consequently, it is important to utilize any substance that can more widely limit viral effects. Often, as in the case of covid-19, there is little likelihood of developing a vaccine or antiviral within a year of the emergence of such a devastating infection. Utilizing or developing more generic antivirals is a significant challenge, given that viruses can vary considerably as to the their effects, including on the immune system. For example, a general antiviral requirement for influenza and covid-19 would be for a treatment that limits the initial innate immune-associated "cytokine storm" where evident, while also acting to increase the efficacy of the adaptive immune response. 2 However, for the Ebola virus, such initial dampening of the innate immune response is not so clinically relevant. Allowing for such variability in virus effects, melatonin has emerged as a top candidate for protection against an array of different viruses, including the coronavirus. [3] [4] [5] This would seem to arise from the close evolution of melatonin within the emerging mitochondria in the first single-cellular organsims, allowing melatonin to be intimately associated with mitochondrial function, and thereby with immune system regulation. 6 The interactions of our "bacterial-driven" coexistence with viruses have provided a "War of the Worlds" from which plant and animal evolution have emerged, and in which evolution has acted to tolerate and limit rather than annihilate. Melatonin is an important aspect of our interactions with viruses. As data pertaining to the pathophysiology of covid-19 have still to emerge, the current article focusses primarily on the role of melatonergic pathway in the management of influenza viruses, as well as highlighting its potential utility in supporting people at high risk of fatality from influenza viruses and covid-19. At the time of writing, data from China and Italy indicate that the elderly are at far higher risk of covid-19 linked mortality, primarily as a consequence of ageingassociated conditions, such as cardiovascular, pulmonary, and diabetic disorders as well as in immune-compromised conditions. Melatonin has clinical utility in all of these health conditions, suggesting its utility in buffering against covid-19 interactions with these medical conditions. However, the interactions of the melatonergic pathway with viruses may be more complex than ameliorative effects on ageingassociated preexisting medical conditions. First, the melatonergic pathway is reviewed and how this pathway may interact with the effects of the influenza, covid-19, and other viruses. This has treatment implications as well as providing indications as to important future research on how an understanding of human physiological systems can provide treatment targets that regulate the impact of viral infections, including influenza, and covid-19 driven pathophysiology. Melatonin is classically associated with its night-time release from the pineal gland, where its effects on circadian entrainment have long been recognized. Melatonin modulates cellular function via a number of processes, including the activation of an intracellular signalling pathways and transcription factors, which act to dampen inflammatory activity. Melatonin is also a powerful antioxidant and antiinflammatory that mediates many of its effects via the optimization of mitochondrial function. Emerging data indicate that the melatonergic pathway is evident in all cells, not only those of the pineal gland, and that it may be predominantly present within mitochondria. Figure 1 shows the enzymes and factors forming the melatonergic pathway, and how different processes can modulate this pathway. Melatonin is derived from tryptophan, via its conversion to serotonin. Arylalkylamine N-acetyltransferase (AANAT) converts serotonin to N-acetylserotonin (NAS), which is then converted to melatonin by acetylserotonin methyltransferase (ASMT). However, variations in the NAS/melatonin ratio occur and have been largely ignored in previous research, with melatonin synthesis having been seen as the ultimate aim of the melatonergic pathway. A number of factors may act to regulate the NAS/melatonin ratio by a variety of mechanisms in different cell types, including O-demethylation/ cytochrome P450 (CYP)2C19, CYP1B1, ATP, and the purinergic receptor (P2Y1), as well as intercellular glutamate and metabotropic glutamate receptor (mGluR5) activation. [7] [8] [9] [10] [11] [12] [13] Variations in the NAS/melatonin ratio exist may be of significant clinical importance in a range of medical conditions, including glioblastoma 14 and multiple sclerosis. 15 Although NAS and melatonin can have similar antioxidant and antiinflammatory effects, the NAS/melatonin ratio may be of importance given that NAS activates the brain derived neurotrophic factor (BDNF) receptor, TrkB, as well as inducing BDNF. Two products of the kynurenine pathway, kynurenic acid, and kynurenine, can activate the aryl hydrocarbon receptor (AhR), which then induces CYP1B1. This allows proinflammatory cytokines, cortisol and oxidative stress, which increase indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO), to increase AhR ligands, as well as other kynurenine pathway products. Consequently, proinflammatory conditions as well as heightened levels of psychological stress and oxidative stress not only decrease tryptophan availability for the serotonergic and melatonergic pathways, but may also modulate the NAS/melatonin ratio, including via AhR activation ( Figure 1 ). Such data would indicate that the NAS/melatonin ratio may be an important sensor of wider body systems, with consequences for intracellular and extracellular function. The circadian entrainment induced by pineal melatonin is strongly driven by melatonin's upregulation of the circadian gene, Bmal1, which seems to mediate many of melatonin's effects in mitochondria. Bmal1 inhibits pyruvate dehydrogenase kinase (PDK), leading to the disinhibition of the pyruvate dehydrogenase complex (PDC). PDC drives the conversion of pyruvate to acetyl-coenzyme A (acetyl-CoA) in mitochondria, thereby increasing the tricarboxylic acid (TCA) cycle, oxidative phosphorylation (OXPHOS) and ATP production. Acetyl-CoA is also a necessary co-substrate for AANAT, and therefore allows pineal melatonin via the Bmal1-PDK-PDC path to increase the activation of the mitochondrial melatonergic pathway. For this to happen, AANAT needs to be stabilized by 14-3-3 protein, which is present within the mitochondrial matrix. 16, 17 It has been proposed that AANAT may also be stabi- Acetyl-CoA Symptom Severity The cytokine storm and stress can increase gut dysbiosis/permeability, further contributing to cytokine induced IDO and TDO, leading to kynurenine and kynurenic acid, which activate the AhR to increase CYP1B1 and regulate the NAS/Melatonin ratio. Other factors, including CYP2C19, mGluR5, P2Y1, and O-demethylation can also regulate the NAS/melatonin ratio. The miRNAs, miR-7, miR-375, and miR-451 are increased following many viral infections, thereby suppressing 14-3-3 and the stabilization of AANAT, leading to melatonergic pathway inhibition. The suppression of melatonin, including from an increase in the NAS/melatonin ratio, attenuates melatonin's induction of Bmal1 and therefore the circadian regulation of mitochondria. Bmal1 induces PDC, leading to an increase in OXPHOS, the TCA cycle and the acetyl-CoA that is a necessary co-substrate for AANAT and melatonergic pathway activation. The decrease in pineal and mitochondrial melatonin contributes to an increase in the replication and severity of many viral infections. The arrows indicate "stimulation", with a crossed-line indicating "inhibitory" 14-3-3-like motif in its C-terminal within the mitochondrial matrix. 18 The pineal melatonin/mitochondrial melatonin path may be most important in immune cells, although relevant in all cells subject to circadian regulation by pineal melatonin. The daytime activation of immune cells is associated with glycolytic metabolism, which pineal melatonin resets to OXPHOS, thereby inducing more quiescent immune cell phenotyes. It is by such processes that immune cells are "dampened" at night. However, in the presence of indicants of required immuneinflammatory activity at night, proinflammatory cytokines can "switch off" pineal melatonin production, thereby forming another branch of the immune-pineal axis. 19 As such, the circadian rhythm, as driven by pineal melatonin, is a powerful immune regulator, with effects that can include Viruses can have quite distinct interactions with the host over the course of an infection, making generalizations across different viruses impossible. However, some factors have been found to regulate the effects of many different viruses. One such factor is the AhR. The AhR has a number of endogenous and exogenous ligands, includ- Overall, the AhR may be an important link between the initial "cytokine storm" and alterations in mitochondrial and immune cell function, including via alterations in the melatonergic pathway. The influence of the circadian rhythm is also seen following influenza vaccination where the timing of vaccination and of sample collection modulates the B-cell response measures, especially in the elderly. 24 The host circadian rhythm is a significant regulator of the response to viral infection. Preclinical data show that irrespective of the viral burden, survival following influenza viral infection is determined by the circadian influence on the patterning of the immune response. 25 The circadian gene, Bmal1, is a significant inhibitor of herpes simplex virus (HSV)-1 and influenza viruses, highlighting the role of circadian factors in the regulation of viral infections. 26 As the loss of the circadian rhythm can increase viral replication, viruses can act to sabotage circadian regulation, exemplified by HSV-1 suppression of Bmal1. 26 This overlaps to data in the lung, where pulmonary airway epithelial cell Bmal1 regulates the response to the influenza virus, 27 with the influenza virus also decreasing Bmal1, thereby contributing to the circadian disruption induced by this virus. 28 Such data highlight the circadian nature of host physiology, including in many virus-relevant pathways, upon which viruses act to promote their survival and proliferation. As noted, the effects of pineal melatonin include Bmal1 induction, which is a major driver of pineal melatonin's influence on circadian rhythms, with Bmal1 acting to regulate mitochondrial metabolism. The importance of such processes is given some support by data in humans with a severe influenza infection and associated poor survival rates. Severe influenza and covid-19 infections seem driven by an initial "cytokine storm", with the increase in proinflammatory cytokines acting to suppress pineal melatonin production. 29 This is the essence of the immune-pineal axis, 19 whereby proinflammatory cytokines act to signal the need for an ongoing immune response and thereby prevent its suppression by pineal melatonin. The major driver of the multiorgan failure that is evident in severe influenza infection is the dysregulation of mitochondrial metabolism, 30 and the lost influence of decreased pineal melatonin on such metabolic dysregulation. An elevation in cellular trypsin, as a hemagglutinin processing protease for viral multiplication, is often an aspect of this, leading to the "influenza virus-cytokine-trypsin" cycle, which is coupled to a decrease in mitochondrial ATP. 30 Work on the "influenza virus-cytokine-trypsin" cycle has led to new proposed treatments, which target the ATP crisis and multi- inflammasome, 32 with the regulation of the NLRP3 inflammasome being taken over by viruses. 33 As melatonin is a significant inhibitor of the NLRP3 inflammasome, 34 the suppression of melatonin production, both pineal and mitochondrial, by viruses is likely to be an important aspect of how viruses disengage the NLRP3 inflammasome from physiological processes. It should also be noted that IL-18 is induced along with IL-1β from NLRP3 inflammasome activation, with IL-18 being relatively under-investigated in viral research, as in many other medical conditions. 35 There is a growing interest in the role of the gut microbiome across a host of diverse medical conditions, including neurodegenerative and psychiatric conditions, 44 but also immune-mediated conditions such as multiple sclerosis and arthritis. 15, 45 In line with this, recent data show that many viral infections, including influenza, drive changes in the gut and lung microbiomes, 46 with viral-mediated changes in the gut including gut dysbiosis and increased gut permeability. These authors also show how such changes in the gut microbiome/permeability can contribute to secondary bacterial pneumonia. 46 Butyrate is also an immune-suppressant via its capacity to disinhibit PDC and thereby increase mitochondrial OXPHOS, TCA cycle, and acetyl-CoA for the melatonergic pathway. 17 It seems not unlikey that butyrate therefore acts on the mitochondrial melatonergic pathway to increase melatonin production, as suggested by its induction of the melatonergic pathway in intestinal epithelial cells. 49 The increase in proinflammatory cytokines and the "cytokine storm" that can contribute to viral infection severity and fatality are positively regulated by the activation of the sympathetic nervous system, as shown with influenza virus infection. 57 These authors also showed sympathetic nervous system activation to increase pulmonary pneumonia in a preclinical model, with the inhibition of the sympathetic nervous system increasing survival. 57 Some of the effects of the sympathetic nervous system may be mediated by an increase release of not only catecholamines, but also neuropeptide Y (NPY), the release of which from monocytes also contributes to influenza-associated fatality. 58 In contrast, the activation of the parasympathetic nervous system following the vagal nerve release of acetylcholine, affords protection against some viral infections via the activation of the alpha 7 acetylcholine nicotinic receptor (α7nAChR), 59 including decreasing macrophage inflammatory responses. 60 It should be noted that the α7nAChR is intimately associated with melatonin, being positively regulated by pineal melatonin over the circadian rhythm, 61 whilst the impact of melatonin in preventing gut permeability under challenge is mediated by its induction of vagal nerve ACh release and subsequent α7nAChR activation. 62 As such, the viral suppression of melatonin will be associated with a decrease in its induction of the α7nAChR and vagal ACh, thereby decreasing the viral-and immune-suppressive activity of vagal activated α7nAChRs. It should also be noted that the α7nAChR is expressed on the mitochondria outer membrane, suggesting more direct impacts on mitochondrial function, including in immune cells and in the regulation of mitochondria Ca2+ influx. 63, 64 Overall, shifts in the balance of the sympathetic/parasympathetic nervous systems may be another aspect of viral infections. This is another route whereby the viral regulation of the melatonergic pathway can act on wider systemic regulatory processes in a manner to increase viral severity and decrease host survival. It is also noteworthy that increased gut dysbiosis/permeability is fre- drial optimization effects as well as its induction of the melatonergic pathway and ability to decrease the gut permeability that is associated with high risk preexisting medical conditions. Overall, there are biomedical, financial, and moral reasons for developing and testing interventions that may immediately limit the impact of viral infections. Not applicable. The evolution of seasonal influenza viruses Potential utility of melatonin in deadly infectious diseases related to the overreaction of innate immune response and destructive inflammation Network-based repurposing for human coronavirus Treatment of Ebola and other infectious diseases: melatonin "goes viral Ebola virus: melatonin as a readily available treatment option Mitochondria: the birth place, battle ground and the site of melatonin metabolism in cells Integrating pathophysiology in migraine: Role of the gut microbiome and melatonin Metabolism of melatonin by human cytochromes p450 Characterisation of P2Y(1)-like receptor in cultured rat pineal glands Purinergic and noradrenergic cotransmission in the rat pineal gland Adenosine triphosphate inhibits melatonin synthesis in the rat pineal gland Modulation of pineal melatonin synthesis by glutamate involves paracrine interactions between pinealocytes and astrocytes through NF-κB activation Hydroxyindole-Omethyltransferase is another target for L-glutamate-evoked inhibition of melatonin synthesis in rat pinealocytes Role of mitochondria Nacetylserotonin/melatonin ratio in mediating effects of miR-451 and aryl hydrocarbon receptor and in coordinating wider biochemical changes Multiple sclerosis: Melatonin, orexin, and ceramide interact with platelet activation coagulation factors and gut-microbiome-derived butyrate in the circadian dysregulation of mitochondria in glia and immune cells Inhibition of mitochondrial pyruvate dehydrogenase kinase: A proposed mechanism by which melatonin causes cancer cells to overcome aerobic glycolysis, limit tumor growth and reverse insensitivity to chemotherapy Daytime orexin and night-time melatonin regulation of mitochondria melatonin: roles in circadian oscillations systemically and centrally in breast cancer symptomatology Preventive measures to slow down the progression of Parkinson's disease Immune-pineal axis-acute inflammatory responses coordinate melatonin synthesis by pinealocytes and phagocytes Aryl hydrocarbon receptor signaling modulates antiviral immune responses: ligand metabolism rather than chemical source is the stronger predictor of outcome Genome-wide transcriptional analysis reveals novel AhR targets that regulate dendritic cell function during influenza A virus infection Interactions of tryptophan and its catabolites with melatonin and the alpha 7 nicotinic receptor in central nervous system and psychiatric disorders: Role of the aryl hydrocarbon receptor and direct mitochondria regulation Murine coronavirus infection activates the aryl hydrocarbon receptor in an indoleamine 2,3-dioxygenase-independent manner, contributing to cytokine modulation and proviral TCDD-inducible-PARP expression The effect of timing of influenza vaccination and sample collection on antibody titers and responses in the aged Circadian control of lung inflammation in influenza infection Cell autonomous regulation of herpes and influenza virus infection by the circadian clock Genome-wide effect of pulmonary airway epithelial cell-specific Bmal1 deletion Influenza A virus-dependent remodeling of pulmonary clock function in a mouse model of Pineal melatonin and the innate immune response: the TNF-alpha increase after cesarean section suppresses nocturnal melatonin production Energy metabolic disorder is a major risk factor in severe influenza virus infection: Proposals for new therapeutic options based on animal model experiments IL-1β is a key cytokine that induces trypsin upregulation in the influenza virus-cytokinetrypsin cycle Zika virus infection induces host inflammatory responses by facilitating NLRP3 inflammasome assembly and interleukin-1β secretion NLRP3 inflammasome-A key player in antiviral responses TLR2-melatonin feedback loop regulates the activation of NLRP3 inflammasome in murine allergic airway inflammation Alzheimer's and seizures: interleukin-18, indoleamine 2,3-dioxygenase and quinolinic Acid IL-1β/IL-6/CRP and IL-18/ferritin: distinct inflammatory programs in infections Computational and experimental insights into the circadian effects of SIRT1 Sirtuin 1 regulates mitochondrial function and immune homeostasis in respiratory syncytial virus infected dendritic cells Sirtuins are evolutionarily conserved viral restriction factors Melatonin mitigates mitochondrial meltdown: interactions with SIRT3 miR-451 regulates dendritic cell cytokine responses to influenza infection Influenza A virus infection of human respiratory cells induces primary microRNA expression MiR-375 has contrasting effects on newcastle disease virus growth depending on the target gene Gut dysbiosis dysregulates central and systemic homeostasis via suboptimal mitochondrial function: assessment, treatment and classification implications Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism Gut dysbiosis dysregulates central and systemic homeostasis via decreased melatonin and suboptimal mitochondria functioning: pathoetiological and pathophysiological implications Sodium butyrate protects mice from the development of the early signs of non-alcoholic fatty liver disease: role of melatonin and lipid peroxidation Histone deacetylase inhibition protects mice against lethal postinfluenza pneumococcal infection Together forever: bacterial-viral interactions in infection and immunity TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection The endotoxin-induced pulmonary inflammatory response is enhanced during the acute phase of influenza infection Gut dysbiosis-derived exosomes trigger hepatic steatosis by transiting HMGB1 from intestinal to liver in mice Bacterial lipopolysaccharide destabilizes influenza viruses Sodium butyrate enhances intestinal integrity, inhibits mast cell activation, inflammatory mediator production and JNK signaling pathway in weaned pigs Cutting edge: sympathetic nervous system increases proinflammatory cytokines and exacerbates influenza A virus pathogenesis Pulmonary phagocyte-derived NPY controls the pathology of severe influenza virus infection Nicotine inhibits the production of proinflammatory cytokines of mice infected with coxsackievirus B3 Identification and characterization of poly(I:C)-induced molecular responses attenuated by nicotine in mouse macrophages Is modulation of nicotinic acetylcholine receptors by melatonin relevant for therapy with cholinergic drugs? Melatonin decreases duodenal epithelial paracellular permeability via a nicotinic receptordependent pathway in rats in vivo Linking the biological underpinnings of depression: role of mitochondria interactions with melatonin, inflammation, sirtuins, tryptophan catabolites, DNA repair and oxidative and nitrosative stress, with consequences for classification and cognition Mitochondria express α7 nicotinic acetylcholine receptors to regulate Ca2+ accumulation and cytochrome c release: study on isolated mitochondria Predictors of fatality in influenza A virus subtype infections among inpatients in the 2015-2016 season Intestinal permeability and IgA provoke immune vasculitis linked to cardiovascular inflammation Increased gut permeability in cancer cachexia: mechanisms and clinical relevance Mitochondrial dynamic dysfunction as a main triggering factor for inflammation associated chronic non-communicable diseases Impact of circadian disruption on cardiovascular function and disease Timing matters: circadian rhythm in sepsis, obstructive lung disease, obstructive sleep apnea, and cancer Left ventricular hypertrophy: roles of mitochondria CYP1B1 and melatonergic pathways in co-ordinating wider pathophysiology Idiopathic pulmonary fibrosis (IPF) signaling pathways and protective roles of melatonin A new prospective on the role of melatonin in diabetes and its complications Aging increases the severity of colitis and the related changes to the gut barrier and gut microbiota in humans and mice its DNA and telomeres in ageing and human population Circadian rhythms, nutrition and implications for longevity in urban environments Mitochondria: central organelles for melatonin's antioxidant and anti-aging actions The ancestral environment shapes antiviral CD8+ T cell responses across generations. iScience Melatonin: Roles in influenza, Covid-19, and other viral infections The authors declare no potential conflict of interest.